Related Experiment Videos
Chlamydia trachomatis and oral contraceptive use: a quantitative review
1Department of Population Sciences, Harvard School of Public Health, Boston.
Genitourinary Medicine
|August 1, 1992
Summary
Oral contraceptive use is associated with an almost twofold increased risk of chlamydia trachomatis infection. Barrier methods offer significant protection against this common sexually transmitted disease.
Area of Science:
- Epidemiology
- Public Health
- Infectious Diseases
Background:
- Chlamydia trachomatis is a significant sexually transmitted disease.
- Oral contraceptive use is increasing globally, especially in developing nations.
- Previous studies suggest a link between oral contraceptive use and higher rates of C. trachomatis infection.
Purpose of the Study:
- To evaluate the association between oral contraceptive use and Chlamydia trachomatis infection.
- To synthesize findings from published studies between 1972 and 1990.
Main Methods:
- Meta-analysis of prospective and case-control studies.
- Pooled estimation of unadjusted odds ratios.
- Subgroup analysis based on study quality, C. trachomatis prevalence, and contraceptive comparison.
Main Results:
- A pooled odds ratio of 1.93 indicated nearly a twofold increased risk of chlamydial infection for oral contraceptive users.
- This increased risk was consistent across studies regardless of quality or prevalence.
- The risk increased to 2.91 when oral contraceptives were compared to barrier methods, which showed a protective effect (OR=0.34).
Conclusions:
- The association between oral contraceptive use and increased chlamydial infection risk is supported by available evidence.
- Limitations include potential confounding factors like sexual behavior and age in component studies.
- Promoting barrier methods is crucial due to their demonstrated protective effect against STDs.